Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies

Mateusz Legut, Dominik Lipka, Nina Filipczak, Adriana Piwoni, Arkadiusz Kozubek, Jerzy GubernatorDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wrocław, Wrocław, PolandAbstract: This paper describes a novel formulation of antineoplastic drug: mitoxantrone loaded into li...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Legut M, Lipka D, Filipczak N, Piwoni A, Kozubek A, Gubernator J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/fd7d52ed25924c09b6b003ec4d50c6fd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fd7d52ed25924c09b6b003ec4d50c6fd
record_format dspace
spelling oai:doaj.org-article:fd7d52ed25924c09b6b003ec4d50c6fd2021-12-02T05:17:41ZAnacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies1178-2013https://doaj.org/article/fd7d52ed25924c09b6b003ec4d50c6fd2014-01-01T00:00:00Zhttp://www.dovepress.com/anacardic-acid-enhances-the-anticancer-activity-of-liposomal-mitoxantr-a15613https://doaj.org/toc/1178-2013 Mateusz Legut, Dominik Lipka, Nina Filipczak, Adriana Piwoni, Arkadiusz Kozubek, Jerzy GubernatorDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wrocław, Wrocław, PolandAbstract: This paper describes a novel formulation of antineoplastic drug: mitoxantrone loaded into liposomal carriers enriched with encapsulated anacardic acid in the liposomal bilayer using a vitamin C gradient. Anacardic acid is a potent epigenetic agent with anticancer activity. This is the first liposomal formulation to combine an actively encapsulated drug and anacardic acid. The liposomes were characterized in terms of basic parameters, such as size, zeta potential, optimal drug-to-lipid ratio, loading time and temperature, and stability at 4°C and in human plasma in vitro. The formulation was found to be stable, and the loading process was rapid and efficient (drug-to-lipid ratio of up to 0.3 with over 90% efficiency in 5 minutes). The cytotoxicity of these formulations was assessed using the human melanoma cell lines A375 and Hs294T and the normal human dermal fibroblast line. The results showed that anacardic acid and to a smaller extent vitamin C significantly increased the cytotoxicity of the drug towards melanoma compared to ammonium sulfate liposomes. On the other hand, vitamin C and anacardic acid both protected normal cells from damage caused by the drug. The formulation combining anacardic acid, vitamin C, and mitoxantrone showed promising results in terms of cytotoxicity and cytoprotection. Therefore, it has potential for anticancer treatment.Keywords: anacardic acid, vitamin C, ascorbic acid, liposomes, mitoxantrone, melanomaLegut MLipka DFilipczak NPiwoni AKozubek AGubernator JDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 653-668 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Legut M
Lipka D
Filipczak N
Piwoni A
Kozubek A
Gubernator J
Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
description Mateusz Legut, Dominik Lipka, Nina Filipczak, Adriana Piwoni, Arkadiusz Kozubek, Jerzy GubernatorDepartment of Lipids and Liposomes, Faculty of Biotechnology, University of Wrocław, Wrocław, PolandAbstract: This paper describes a novel formulation of antineoplastic drug: mitoxantrone loaded into liposomal carriers enriched with encapsulated anacardic acid in the liposomal bilayer using a vitamin C gradient. Anacardic acid is a potent epigenetic agent with anticancer activity. This is the first liposomal formulation to combine an actively encapsulated drug and anacardic acid. The liposomes were characterized in terms of basic parameters, such as size, zeta potential, optimal drug-to-lipid ratio, loading time and temperature, and stability at 4°C and in human plasma in vitro. The formulation was found to be stable, and the loading process was rapid and efficient (drug-to-lipid ratio of up to 0.3 with over 90% efficiency in 5 minutes). The cytotoxicity of these formulations was assessed using the human melanoma cell lines A375 and Hs294T and the normal human dermal fibroblast line. The results showed that anacardic acid and to a smaller extent vitamin C significantly increased the cytotoxicity of the drug towards melanoma compared to ammonium sulfate liposomes. On the other hand, vitamin C and anacardic acid both protected normal cells from damage caused by the drug. The formulation combining anacardic acid, vitamin C, and mitoxantrone showed promising results in terms of cytotoxicity and cytoprotection. Therefore, it has potential for anticancer treatment.Keywords: anacardic acid, vitamin C, ascorbic acid, liposomes, mitoxantrone, melanoma
format article
author Legut M
Lipka D
Filipczak N
Piwoni A
Kozubek A
Gubernator J
author_facet Legut M
Lipka D
Filipczak N
Piwoni A
Kozubek A
Gubernator J
author_sort Legut M
title Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
title_short Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
title_full Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
title_fullStr Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
title_full_unstemmed Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
title_sort anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/fd7d52ed25924c09b6b003ec4d50c6fd
work_keys_str_mv AT legutm anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies
AT lipkad anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies
AT filipczakn anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies
AT piwonia anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies
AT kozubeka anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies
AT gubernatorj anacardicacidenhancestheanticanceractivityofliposomalmitoxantronetowardsmelanomacelllinesndashinvitrostudies
_version_ 1718400510502895616